Serum Diamine Oxidase in Pseudoallergy in the Pediatric Population
Histamine intolerance (pseudoallergy) is a poorly investigated type of food hypersensitivity. The main enzyme responsible for histamine degradation in the extracellular matrix is diamine oxidase (DAO). Disturbances in the concentration or activity of DAO may lead to the development of clinical signs of allergy. The aim of the present work was to assess the DAO concentration, peripheral blood morphology, lymphocytes phenotyping (CD3+, CD4+, CD8+, CD19+, NK cells, NKT cells, and activated T-cells), and natural regulatory Treg (nTregs) cell population (CD4+, CD25+, CD127low, and FoxP3) in 34 pediatric patients with histamine-dependent syndromes. Patients were divided into two groups: classical allergy and pseudoallergy on the basis of IgE concentration. The investigation was based on the analysis of peripheral blood samples. A significantly lower serum DAO, both total and specific IgE, concentration was found in the pseudoallergy group compared with the allergy group. There were no significant differences in blood morphology or lymphocyte populations. A similar level of nTreg lymphocytes was also found in both groups, although it was lower than that present in healthy individuals. The findings suggest that the serum DAO is responsible for the symptoms of histamine intolerance. Moreover, a general decrease in nTreg cells in comparison with healthy individuals may lead to symptom aggravation.
KeywordsAllergy Angioedema Dermal lesions Headache Immunological disorders Stomachache
We thank Mr. Piotr Murawski, Head of ICT Department of the Military Institute of Medicine for assistance in statistical elaboration.
Conflicts of Interest
The authors declare no conflicts of interest in relation to this article.
- Czerwionka-Szaflarska M, Zielińska-Duda H (2009) Allergy and food intolerance in children. Fam Med Prim Care Rev 11:577–584Google Scholar
- Górski P (2007) Histamine- a mediator the longer known the more unknown. Alergia 4:33–35Google Scholar
- Høst A, Andrae S, Charkin S, Diaz-Vázquez C, Dreborg S, Eigenmann PA, Friedrichs F, Grinsted P, Lack G, Meylan G, Miglioranzi P, Muraro A, Nieto A, Niggemann B, Pascual C, Pouech MG, Rancé F, Rietschel E, Wickman M (2003) Allergy testing in children: why, who, when and how. Allergy 58(7):559–569CrossRefPubMedGoogle Scholar
- Jarisch R (2004) Histamin-Intoleranz. Histamin und Seekrankheit, 2nd edn. Georg Thieme Verlag, Stuttgart/New YorkGoogle Scholar
- Kalicki B, Lewicki S, Stankiewicz W, Jung A, Rustecka A, Turkowska M, Rutkowski P, Bodera P, Zdanowski R (2013) Examination of correlation between vitamin D-3 (25-OHD3) concentration and percentage of regulatory T lymphocytes (FoxP3) in children with allergy symptoms. Cent Eur J Immunol 38(1):70–75CrossRefGoogle Scholar
- Karpińska-Gasztoł E, Gutowska M, Zdunowski P, Zgliczyńskiet W (2014) Plethoric facies – multidisciplinary problem. Histamine intolerance secondary to reduced diamine oxidase activity. Post N Med 27(12):843–846. (Article in polish)Google Scholar
- Lipińska-Opałka A, Wawrzyniak A, Lewicki S, Zdanowski R, Kalicki B (2017) Evaluation of immune indices and serum vitamin D content in children with atopic dermatitis. Adv Exp Med Biol. doi: 10.1007/5584_2017_20
- Maintz L, Bieber T, Novak N (2006) Histamine intolerance in clinical practice. Dtsch Arztebl 103(51–52):A3477–A3483Google Scholar
- Schwelberger HG, Ahrens F, Fogel WA, Sánchez-Jiménez F (2013) Histamine metabolism. In: Stark H (ed) Histamine H4 receptor: a novel drug target in Immunoregulatory and inflammatory diseases. Versita, London, pp 63–101Google Scholar